MILLS KENNETH T. (President and CEO) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2026ACC: 0001652824-26-000003
DirectorOfficer· President and CEO
Since Aug 2018
+56.41K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
56.41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.81K
Price / share
—
Trade value
—
% of position
2.0%
5/29/2026
486.12K→495.93K
Total
Net shares
+9.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | A · Award | +9.81K | — | — | 2.0% | 486.12K | 495.93K |
| Total | +9.81K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
46.60K shares
Shares
+46.60K
Strike price
7.01
Held after
46.60K
Exercisable
—
5/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock46.60K shares | 5/29/2026 | A · Award | +46.60K | 7.01 | — | 46.60K |